L (2010-2017)

STUDIES ON CONDITIONS and RELATED ARTICLES 2010-2017

+Studies in 2000-2009 List
*Studies in Pre-2000 List

LEGIONNAIRES DISEASE + (Not Good News)
LEISHMANIASIS +
LIVER DISEASE-NON HEPATITIS*+ (See Also HEPATITIS)
LONG TERM USE EFFECTS*+
LUNG FUNCTION*+
LUPUS ERYTHEMATOSUS (See News Articles 2010-2017)
LYME DISEASE + (See News Articles 2010-2017)


LEGIONNAIRES DISEASE 
Legionnaires disease in cannabis smokers (full-2011) http://journal.publications.chestnet.org/article.aspx?articleid=1086681


LEISHMANIASIS 
Antileishmanial phytochemical phenolics: Molecular docking to potential protein targets (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24463105


LIVER DISEASE-NON HEPATITIS
Effect of (-)-Delta(9)-tetrahydrocannabinoid on the hepatic redox state of mice (full–2010) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2010007500015&lng=en&nrm=iso&tlng=en
Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829220/?tool=pubmed
Recent advances in the understanding of the role of the endocannabinoid system in liver diseases (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033442/
Role of the endocannabinoid system in alcoholic liver disease (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/21525760
Cannabinoid receptor type 1 expression modulates alcohol-induced liver fibrosis: Role of Acetaldehyde (abst–2010)  https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0029-1246364
Endogenous cannabinoids in liver disease: Many darts for a single target (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19758727
Endocannabinoids in liver disease (full–2011) http://onlinelibrary.wiley.com/doi/10.1002/hep.24077/full
Hyperactivation of anandamide synthesis and regulation of cell-cycle progression via
cannabinoid type 1 (CB1) receptors in the regenerating liver (full–2011) http://www.pnas.org/content/108/15/6323.full
Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis (full–2011)
http://www.nature.com/cddis/journal/v2/n6/pdf/cddis201152a.pdf
Cannabidiol, a Major Phytocannabinoid, as a Potent Atypical Inhibitor for Cytochrome P450 2D6 (full–2011) http://dmd.aspetjournals.org/content/early/2011/08/05/dmd.111.041384.long
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081988/pdf/nihms278422.pdf
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
Central Endocannabinoid Signaling Regulates Hepatic Glucose Production and Systemic Lipolysis (full–2011) http://diabetes.diabetesjournals.org/content/60/4/1055.full
top
Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration (full-2011) http://onlinelibrary.wiley.com/doi/10.1002/hep.23779/full
Hepatic n-3 Polyunsaturated Fatty Acid Depletion Promotes Steatosis and Insulin Resistance in Mice: Genomic Analysis of Cellular Targets (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154437/
Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057300/
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and cell death (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081988/
Altered endocannabinoid signalling after a high-fat diet in Apoe(-/-) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance (full–2011) http://link.springer.com/article/10.1007/s00125-011-2274-6/fulltext.html
Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating kupffer cell polarization in mice (full–2011) http://onlinelibrary.wiley.com/doi/10.1002/hep.24524/full
A new cannabinoid 2 receptor agonist HU-910 attenuates oxidative stress, inflammation, and cell death associated with hepatic ischemia/reperfusion injury (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423243/
Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21930120
Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21704641/abstract/Identification_of_cytochrome_P450_enzymes_responsible_for_metabolism_of_cannabidiol_by_human_liver_microsomes_
The novel endocannabinoid virodhamine selectively induces cell death in hepatic stellate cells but not in hepatocytes (abst–2011) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0030-1269511
Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21930120
Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21704641/abstract/Identification_of_cytochrome_P450_enzymes_responsible_for_metabolism_of_cannabidiol_by_human_liver_microsomes_
The novel endocannabinoid virodhamine selectively induces cell death in hepatic stellate cells but not in hepatocytes (abst–2011) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0030-1269511
Effect of cannabidiol treatment in alimentary induced fatty liver (abst–2011) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0031-1278456
Peripheral effects of the endocannabinoid system in energy homeostasis: adipose tissue, liver and skeletal muscle (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21336842
Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic Fatty liver disease (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0042259
Prevention of Fibrosis Progression in CCl4-Treated Rats: Role of the Hepatic Endo-cannabinoid and Apelin Systems (full–2012)  http://jpet.aspetjournals.org/content/340/3/629.full
Δ(8) -Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB(2) receptors (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423240/
Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats (full–2012)  http://onlinelibrary.wiley.com/doi/10.1002/hep.25625/full
top
Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738192/
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharma-cological strategies and therapeutic possibilities (full–2012)  http://rstb.royalsocietypublishing.org/content/367/1607/3353.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Characterization of In Vitro Metabolites of CP 47,497, a Synthetic Cannabinoid, in Human Liver Microsomes by LC-MS/MS (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22931239
The endocannabinoid 2-arachidonoylglicerol decreases calcium induced cytochrome c release from liver mitochondria (abst–2012)  http://www.springerlink.com/content/54jm40088728t0pn/
Serum Metabolic Profiling Study of Hepatocellular Carcinoma Infected with Hepatitis B or Hepatitis C Virus by Using Liquid Chromatography-Mass Spectrometry (abst–2012)  http://pubs.acs.org/doi/abs/10.1021/pr300683a
Influence of G1359A polimorphysm of the cannabinoid receptor gene (CNR1) on insulin resistance and adipokines in patients with non alcoholic fatty liver disease (full–2013) http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112012000500039&lng=en&nrm=iso&tlng=en
Cannabinoid receptor 2 counteracts interleukin-17-induced immune and fibrogenic responses in mouse liver (full–2013)  http://onlinelibrary.wiley.com/doi/10.1002/hep.26598/full
Hepatic Cannabinoid Receptor Type 1 Mediates Alcohol-Induced Regulation of Bile Acid Enzyme Genes Expression Via CREBH (full–2013)  http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0068845
The serine hydrolase ABHD6 Is a critical regulator of the metabolic syndrome (full–2013) http://www.cell.com/cell-reports/fulltext/S2211-1247%2813%2900507-X
Monounsaturated fatty acids generated via stearoyl CoA desaturase-1 are endogenous inhibitors of fatty acid amide hydrolase (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839776/
Cannabidiol is a Potent Inhibitor of the Catalytic Activity of Cytochrome P450 2C19 (full–2013) https://www.jstage.jst.go.jp/article/dmpk/28/4/28_DMPK-12-RG-129/_pdf
Cannabinoid signaling and liver therapeutics (full–2013) http://www.journal-of-hepatology.eu/article/S0168-8278%2813%2900212-2/fulltext
The role of endocannabinoids system in fatty liver disease and therapeutic potentials (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745655/
US Patent Application 20130171145 – METHODS OF TREATING LIVER DISEASE (full–2013) http://www.freepatentsonline.com/y2013/0171145.html
Effects of anandamide on proliferation of and pErk expression in primary hepatic stellate cells of schistosome-induced liver fibrosis mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23663762
Fatty acid amide hydrolase but not monoacyl glycerol lipase controls cell death induced by the endocannabinoid 2-arachidonoyl glycerol in hepatic cell populations (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23806692
top
Curcumin modulates cannabinoid receptors in liver fibrosis in vivo and inhibits extra-cellular matrix expression in hepatic stellate cells by suppressing cannabinoid receptor type-1 in vitro (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24076327
Functional relevance of the cannabinoid receptor 2 – heme oxygenase pathway: A novel target for the attenuation of portal hypertension (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24007798
Protective effect of cannabidiol against cadmium hepatotoxicity in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23993482
The novel endocannabinoid noladin ether holds putative anti-fibrotic properties by selectively inducing cell death in hepatic stellate cells (abst–2013) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0032-1331948
A new face of endocannabinoids in pharmacotherapy. Part II. Role of endocannabinoids
in inflammation-derived cardiovascular diseases (full–2014) http://www.jpp.krakow.pl/journal/archive/04_14/pdf/183_04_14_article.pdf
Endocannabinoid Receptors Gene Expression in Morbidly Obese Women with Nonalcoholic Fatty Liver Disease (full–2014) http://www.hindawi.com/journals/bmri/2014/502542/
Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839256/
Vascular targets for cannabinoids: animal and human studies (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12560/full
Cannabinoid receptor 1 gene polymorphisms and nonalcoholic Fatty liver disease in women with polycystic ovary syndrome and in healthy controls (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127238/
Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112960/
Review article: the endocannabinoid system in liver disease, a potential therapeutic target (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/apt.12673/full
Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue (full–2014) http://onlinelibrary.wiley.com/enhanced/doi/10.1111/bph.12298
Inhibitory effect of synthetic cannabinoids on CYP1A activity in mouse liver micro-somes (link to PDF–2014) https://www.jstage.jst.go.jp/article/jts/39/6/39_815/_article
The peripheral cannabinoid receptor 1 antagonist VD60 efficiently inhibits carbon tetrachloride-intoxicated hepatic fibrosis progression (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24459189
CB1 blockade-induced weight loss over 48 weeks decreases liver fat in proportion to weight loss in humans (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/22828945
Upregulation of Cannabinoid Receptor-1 and Fibrotic Activation of Mouse Hepatic Stellate Cells during Schistosoma J. Infection: Role of NADPH Oxidase (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24657416
Therapeutical Potential of CB2 Receptors in Immune-Related Diseases (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24720538
top
Potential therapeutic applications of cannabinoids in gastrointestinal and liver diseases: Focus on Δ9-tetrahydrocannabinol pharmacology (abst–2014) http://onlinelibrary.wiley.com/doi/10.1002/9781118451281.ch7/summary
Mechanism of endocannabinoids system in glucose metabolism of rats with chronic intermittent hypoxia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25146750
Role of cannabinoid receptors in hepatic fibrosis and apoptosis associated with bile duct ligation in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25179573
Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25497453
Activity of liver enzymes in multiple sclerosis patients with Hot-nature diet and cosupplemented hemp seed, evening primrose oils intervention (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25453518
The antidiabetic and hepatoprotective effects of magnolol on diabetic rats induced by high-fat diet and streptozotocin (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24974464
Protective Role of CB2 Receptor Activation in Galactosamine/LPS-induced Acute Liver Failure Through Regulation of Macrophage Polarization and miRNAs (full–2015) http://jpet.aspetjournals.org/content/early/2015/03/06/jpet.114.220368.long
Cannabidiol Rescues Acute Hepatic Toxicity and Seizure Induced by Cocaine (full–2015) http://www.hindawi.com/journals/mi/2015/523418/
Ultra Low Dose Delta 9-Tetrahydrocannabinol Protects Mouse Liver from Ischemia Reperfusion Injury (full–2015) http://www.karger.com/Article/Pdf/430165
Extraordinary cause of acute gastric dilatation and hepatic portal venous gas: Chronic use of synthetic cannabinoid (full–2015) http://www.wjgnet.com/1007-9327/full/v21/i37/10704.htm
Bisdemethoxycurcumin Induces Apoptosis in Activated Hepatic Stellate Cells via Cannabinoid Receptor 2 (link to PDF–2015) http://www.mdpi.com/1420-3049/20/1/1277
Potent natural products and herbal medicines for treating liver fibrosis (full–2015) http://cmjournal.biomedcentral.com/articles/10.1186/s13020-015-0036-y
α/β Hydrolase Domain-Containing 6 (ABHD6) Degrades the Late Endosomal / Lysosomal Lipid Bis(monoacylglycero)phosphate (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705992/
Management of non-alcoholic fatty liver disease in 2015 (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691699/
Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells (full–2015) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=6466&path%5B%5D=17855
top
Protective effect of Xingnaojia formulation on rats with brain and liver damage caused by chronic alcoholism (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665616/
Orphan nuclear receptor oestrogen-related receptor γ (ERRγ) plays a key role in hepatic cannabinoid receptor type 1-mediated induction of CYP7A1 gene expression (full–2015) http://ajpendo.physiology.org/content/308/7/E583.long
Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoylglycerol and arachidonoyl-ethanolamide, and their metabolites (full–2015) http://www.jleukbio.org/content/97/6/1049.long
Intake of farmed Atlantic salmon fed soybean oil increases hepatic levels of arachidonic acid-derived oxylipins and ceramides in mice (full–2015) http://www.jnutbio.com/article/S0955-2863(15)00021-2/fulltext
Fasiglifam (TAK-875) Inhibits Hepatobiliary Transporters: A Possible Factor Contributing to Fasiglifam-Induced Liver Injury (full–2015) http://dmd.aspetjournals.org/content/43/11/1751.long
CB1R antagonist increases hepatic insulin clearance in fat-fed dogs likely via upregulation of liver adiponectin receptors (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609878/
Two non-psychoactive cannabinoids reduce intra-cellular lipid levels and inhibit hepatosteatosis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25595882
Anandamide Drives Cell Cycle Progression through CB1 Receptors in a Rat Model of Synchronized Liver Regeneration (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25684344
Rimonabant inhibits proliferation, collagen secretion and induces apoptosis in hepatic stellate cells (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25713910
Major urinary protein 1 interacts with cannabinoid receptor type 1 in fatty acid-induced hepatic insulin resistance in a mouse hepatocyte model (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25843798
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25936364
Effects of dietary CLA on n-3 HUFA score and N-acylethanolamides biosynthesis in the liver of obese Zucker rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25912618
CB1 receptor blockade counters age-induced insulin resistance and metabolic dysfunction (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/acel.12438/full
Vaccenic acid suppresses intestinal inflammation by increasing the endocannabinoid anandamide and non-cannabinoid signaling molecules in a rat model of the metabolic syndrome (full–2016) http://www.jlr.org/content/early/2016/02/17/jlr.M066308.long
The Cannabinoid Receptor 2 Protects Against Alcoholic Liver Disease Via a Macrophage Autophagy-Dependent Pathway (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921859/
Immunohistochemical analysis of cannabinoid receptor 1 expression in steatotic rat livers (link to PDF–2016) http://www.spandidos-publications.com/10.3892/etm.2016.3036
The Orphan Nuclear Receptor ERRγ Regulates Hepatic CB1 Receptor-Mediated Fibroblast Growth Factor 21 Gene Expression (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0159425
Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979564/
Human CB1 Receptor Isoforms, present in Hepatocytes and β-cells, are Involved in Regulating Metabolism (full–2016) http://www.nature.com/articles/srep33302
Exposure to a Highly Caloric Palatable Diet during the Perinatal Period Affects the Expression of the Endogenous Cannabinoid System in the Brain, Liver and Adipose Tissue of Adult Rat Offspring (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0165432
Orexin-A represses satiety-inducing POMC neurons and contributes to obesity via stimulation of endocannabinoid signaling (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855580/
Early Low Fat Diet Enriched with Linolenic Acid Reduces Liver Endocannabinoid Tone and Improves Late Glycemic Control After a High Fat Diet Challenge in Mice (full–2016) http://diabetes.diabetesjournals.org/content/65/7/1824.long
Bisphenol A Induces Fatty Liver by an Endocannabinoid-Mediated Positive Feedback Loop (full–2016) http://press.endocrine.org/doi/10.1210/en.2015-1384?url_ver=Z39.88- 2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Identification of New Synthetic Cannabinoid ADB-CHMINACA (MAB-CHMINACA) Metabolites in Human Hepatocytes (full–2016) http://link.springer.com/article/10.1208%2Fs12248-016-0037-5
Long-Term Effects of Prenatal Exposure to Undernutrition on Cannabinoid Receptor Related Behaviors: Sex and Tissue-Specific Alterations in the mRNA Expression of Cannabinoid Receptors and Lipid Metabolic Regulators (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00241/full
In vitro metabolism of a novel synthetic cannabinoid, EAM-2201, in human liver microsomes and human recombinant cytochrome P450s (abst–2016) http://www.sciencedirect.com/science/article/pii/S0731708515302429
Curcumin and hemopressin treatment attenuates cholestasis-induced liver fibrosis in rats: role of CB1 receptors (abst–2016) http://link.springer.com/article/10.1007/s00210-015-1181-7
Cyclooxygenase-2 contributes to the selective induction of cell death by the endocannabinoid 2-arachidonoyl glycerol in hepatic stellate cells (abst–2016) http://www.sciencedirect.com/science/article/pii/S0006291X16300833
Cannabinoid receptor type 1 mediates high-fat diet-induced insulin resistance by increasing forkhead box O1 activity in a mouse model of obesity (abst–2016) http://www.spandidos-publications.com/10.3892/ijmm.2016.2475
top
Cannabinoid receptors are involved in the protective effect of a novel curcumin derivative C66 against CCl4-induced liver fibrosis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26945822
Cannabinoid Receptor 1 Mediates Homing of Bone Marrow-Derived Mesenchymal Stem Cells Triggered by Chronic Liver Injury (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27028843
Endocannabinoids signaling: Molecular mechanisms of liver regulation and diseases (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27100518
Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S0041008X1630076X
Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27117865
Intake of a Western diet containing cod instead of pork alters fatty acid composition in tissue phospholipids and attenuates obesity and hepatic lipid accumulation in mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27155918
Fabp-1 gene ablation impacts brain endocannabinoid system in male mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27167970
β-Caryophyllene attenuates palmitate-induced lipid accumulation through AMPK signaling by activating CB2 receptor in human HepG2 hepatocytes (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27234712
A multicenter retrospective survey of poisoning after consumption of products containing novel psychoactive substances from 2013 to 2014 in Japan (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27314752 FABP1 in wonderland (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27329821
Cannabinoids, inflammation, and fibrosis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27435265
Female Mice are Resistant to Fabp1 Gene Ablation-Induced Alterations in Brain Endocannabinoid Levels (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27450559
FABP1: A Novel Hepatic Endocannabinoid and Cannabinoid Binding Protein (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.biochem.6b00446
Role of cannabis in digestive disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27792038
Serum levels of endocannabinoids are independently associated with nonalcoholic fatty liver disease (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27863097
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416304390
Using proteomics to discover novel biomarkers for fatty liver development and response to CB1R antagonist treatment in an obese mouse model (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27928909
Design, Synthesis and Biological Evaluation of Novel, Non-Brain Penetrant, Hybrid Cannabinoid CB1R Inverse Agonist/Inducible Nitric Oxide Synthase (iNOS) Inhibitors for the Treatment of Liver Fibrosis (abst–2017) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.6b01504
Beta-caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28107775


LONG TERM USE EFFECTS
Effects of cannabis on lung function: a population-based cohort study (full-2010) http://erj.ersjournals.com/content/35/1/42.long
Opioid antagonism enhances marijuana’s effects in heavy marijuana smokers (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2923559/
Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20565525
An Evidence Based Review of Acute and Long-Term Effects of Cannabis Use on Executive Cognitive Functions (full–2011) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037578/
Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045517/
Increased Blood Pressure Following Abrupt Cessation of Daily Cannabis Use (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045206/
Effects of Chronic Marijuana Use on Brain Activity During Monetary Decision-Making (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260974/
Scientific Opinion on the safety of hemp (Cannabis genus) for use as animal feed (full–2011) (deceptive title) http://www.hanf-info.ch/info/en/IMG/pdf/EIHA-11-05-31_EIHA-Statement_on_THC_in_feed.pdf
Popular intoxicants: what lessons can be learned from the last 40 years of alcohol and cannabis regulation? (full–2011) http://www.lufg.com.au/files/media/Popular_intoxicants_what_lessons_can_be_learned.pdf
Characterizing smoking topography of cannabis in heavy users (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641906/
Prolonged excretion half-life of 11-nor-9-carboxy-Δ⁹-THC following cessation in a chronic, heavy marijuana user: implications for liver transplant assessment. (1st page–2011) http://www.psychosomaticsjournal.com/article/S0033-3182%2810%2900028-9/abstract
Marijuana use among older adults in the U.S.A.: user characteristics, patterns of use, and implications for intervention (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21108863
The histopathology of drugs of abuse (abst–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2559.2010.03728.x/abstract
Psychomotor Performance, Subjective and Physiological Effects and Whole Blood Δ9-Tetrahydrocannabinol Concentrations in Heavy, Chronic Cannabis Smokers Following Acute Smoked Cannabis (full–2012) http://jat.oxfordjournals.org/content/36/6/405.full
Prevalences of illicit drug use in people aged 50 years and over from two surveys (full–2012) http://ageing.oxfordjournals.org/content/41/4/553.long
Chronic Cannabis Abuse, Delta-9-tetrahydrocannabinol and Thyroid Function (full–2012) https://www.thieme-connect.com/ejournals/html/10.1055/s-0032-1316342
Acute effects of THC on time perception in frequent and infrequent cannabis users (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581701/
Functional connectivity in brain networks underlying cognitive control in chronic cannabis users (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376324/
A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols) (full–2012) http://msj.sagepub.com/content/18/2/219.long
Dopamine Response to Psychosocial Stress in Chronic Cannabis Users: A PET Study With [11C]-(+)-PHNO (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572464/
A placebo-controlled study to assess Standardized Field Sobriety Tests performance during alcohol and cannabis intoxication in heavy cannabis users and accuracy of point of collection testing devices for detecting THC in oral fluid (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3456923/
top
Assessing topographical orientation skills in cannabis users (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259701/?tool=pubmed
Cannabinoid hyperemesis syndrome: case report of a paradoxical reaction with heavy marijuana use (full–2012) http://www.hindawi.com/journals/crim/2012/757696/
Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: a meta-analysis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22731735
Evaluation of the safety and tolerability profile of Sativex: is it reassuring enough? (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22509986
Implicit Associations and Explicit Expectancies toward Cannabis in Heavy Cannabis Users and Controls (full–2013) http://www.frontiersin.org/Addictive_Disorders_and_Behavioral_Dyscontrol/10.3389/fpsyt.2013.00059/full
Single doses of THC and cocaine decrease proficiency of impulse control in heavy
cannabis users (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12425/full
Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers’ blood on per se drugged driving laws (full–2013) http://www.clinchem.org/content/59/3/519.full?sid=c00c9727-29e8-493c-83b8-456467e158b9
Cannabis use: a perspective in relation to the proposed UK drug-driving legislation (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/dta.1588/full
Effects of marijuana smoking on the lung (full–2013) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201212-127FR#.U903xGN8E24
Cannabis Cue Reactivity and Craving Among Never, Infrequent and Heavy Cannabis Users (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3957117/
Statistics on cannabis users skew perceptions of cannabis use (full–2013) http://journal.frontiersin.org/article/10.3389/fpsyt.2013.00138/full
Marijuana’s dose-dependent effects in daily marijuana smokers (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23937597
Around-the-clock oral THC effects on sleep in male chronic daily cannabis smokers (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23952899
Chronic cannabis abuse, delta-9-tetrahydrocannabinol and thyroid function (letter–2013) https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0032-1316342
Creativity in cannabis-users and in drug addicts in maintenance treatment and in rehabilitation (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23359015
Health outcomes associated with long-term regular cannabis and tobacco smoking (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23501136
Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22878432
Chronic Cannabis Abuse, Delta-9-tetrahydrocannabinol and Thyroid Function (abst–2013) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0033-1336455
THCCOOH concentrations in whole blood: Are they useful in discriminating occasional from heavy smokers? (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24173827
Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium (full–2014) http://onlinelibrary.wiley.com/doi/10.1002/ijc.29036/full
Therapeutic benefits of cannabis: a patient surve (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998228/
top
Couples’ Marijuana Use Is Inversely Related to Their Intimate Partner Violence Over the First 9 Years of Marriage (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282761/
Effects of Marijuana Exposure on Expiratory Airflow: A Study of Adults who Participated in the U.S. National Health and Nutrition Examination Study (full–2014) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201407 -333OC#.VrA9xVJA44A
High-Intensity Cannabis Use and Adherence to Antiretroviral Therapy Among People Who Use Illicit Drugs in a Canadian Setting (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289662/
Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170074/
Long-Term Effectiveness and Safety of Nabiximols (Tetrahydrocannabinol/Cannabidiol
Oromucosal Spray) in Clinical Practice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24943098
Relationship between working-memory network function and substance use: a 3-year longitudinal fMRI study in heavy cannabis users and controls (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24589297
Daily marijuana use is not associated with brain morphometric measures in adolescents or adults (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25632127
Daily marijuana use is not associated with brain morphometric measures in adolescents or adults (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308597/
Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup (full–2015) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201504-195AR#.Vo20QFJwtSE
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26237286
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men (full-2015) http://www.ncbi.nlm.nih.gov/pubmed/26237286
Plasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum Cannabis Smoking in Chronic Frequent Users (full–2015)  http://jat.oxfordjournals.org/content/39/8/580.long
Effects of quitting cannabis on respiratory symptoms (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25837035
Responsible and controlled use: Older cannabis users and harm reduction (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25911027
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drug’s harm to children and adults, but the scientific evidence is seldom clear-cut (article–2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full
Differential effects of self-reported lifetime marijuana use on interleukin-1 alpha and tumor necrosis factor in African American adults (abst–2015) http://link.springer.com/article/10.1007/s10865-015-9625-6
Residual cannabis levels in blood, urine and oral fluid following heavy cannabis use (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25698515
Association Between Lifetime Marijuana Use and Cognitive Function in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study (full–2016) http://archinte.jamanetwork.com/article.aspx?articleid=2484906
Minimal Physical Health Risk Associated With Long-term Cannabis Use—But Buyer Beware (full–2016) http://jama.jamanetwork.com/article.aspx?articleid=2526619 Associations Between Cannabis Use and Physical Health Problems in Early Midlife (full–2016) http://archpsyc.jamanetwork.com/article.aspx?articleid=2526003
Habituation of the startle reflex depends on attention in cannabis users (full–2016) http://bmcpsychology.biomedcentral.com/articles/10.1186/s40359-016-0158-8
Association Between Regular Cannabis Use and Ganglion Cell Dysfunction (full–2016) http://jamanetwork.com/journals/jamaophthalmology/fullarticle/2589167
Retinal Ganglion Cell Dysfunction in Regular Cannabis Users Is the Evidence Strong Enough to Consider an Association? (full–2016) http://jamanetwork.com/journals/jamaophthalmology/fullarticle/2589166
MRI study of neural sensitization to hedonic stimuli in long-term, daily cannabis users (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012952/
Grey Matter Changes Associated with Heavy Cannabis Use: A Longitudinal sMRI Study (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0152482
Comparison of cannabinoids in hair with self-reported cannabis consumption in heavy, light and non-cannabis users (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/dar.12412/full
The effect of cannabis on regular cannabis consumers’ ability to ride a bicycle (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26739323
Abrupt Quitting of Long-term Heavy Recreational Cannabis Use is Not Followed by
Significant Changes in Blood Pressure and Heart Rate (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26761126
top
Cannabinoids: Medical implications (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26912385
Comparing adults who use cannabis medically with those who use recreationally: Results from a national sample (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262964
Are We Using the Right Model of Cannabis Tolerance? (abst–2016) http://www.jsad.com/doi/10.15288/jsad.2016.77.992
The effects of cannabis use on salience attribution: a systematic review (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27866486
Alcohol and cannabis: Comparing their adverse health effects and regulatory regimes (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27908654
Peer Network Counseling as Brief Treatment for Urban Adolescent Heavy Cannabis Users (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/27936376
Medicinal versus recreational cannabis use: Patterns of cannabis use, alcohol use, and cued-arousal among veterans who screen positive for PTSD (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28088054


LUNG FUNCTION
Does cannabis use predispose to chronic airflow obstruction? (full–2010) http://erj.ersjournals.com/content/35/1/3.full?ijkey=d1405bb2fc0ed2aff675335858f284f7f470fbbc&keytype2=tf_ipsecsha
“Bong lung” in cystic fibrosis: a case report (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998526/?tool=pmcentrez
Targeting the cannabinoid pathway limits the development of fibrosis and auto-immunity in a mouse model of systemic sclerosis (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2893662/
Effects of cannabis on lung function: a population-based cohort study (full-2010) http://erj.ersjournals.com/content/35/1/42.long
DOSE-DEPENDENT EFFECTS ON VENTILATION AT REST INDUCED BY HIGH DOSES OF CANNABINOIDS IN RATS (abst–2010) http://www.maneyonline.com/doi/abs/10.1179/acb.2010.115
Cannabinoid effects on ventilation and breathlessness: A pilot study of efficacy and safety (link to download–2011) http://journals.sagepub.com/doi/abs/10.1177/1479972310391283
Honokiol rescues sepsis-associated acute lung injury and lethality via the inhibition of oxidative stress and inflammation (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21279327
The histopathology of drugs of abuse (abst–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2559.2010.03728.x/abstract
Association Between Marijuana Exposure and Pulmonary Function Over 20 Years (full–2012) http://jama.jamanetwork.com/article.aspx?articleid=1104848
Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A(2A) receptor (full–2012) http://www.sciencedirect.com/science/article/pii/S0014299912000052
Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation
in C57BL/6 mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632657/
Honokiol attenuates the severity of acute pancreatitis and associated lung injury via acceleration of acinar cell apoptosis (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22258232
Monoacylglycerol Lipase (MAGL) Inhibition Attenuates Acute Lung Injury in Mice (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808422/
High Times, Low Sats: Diffuse Pulmonary Infiltrates Associated with Chronic Synthetic Cannabinoid Use (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657026/
Endocannabinoid anandamide mediates hypoxic pulmonary vasoconstriction (full–2013) http://www.pnas.org/content/110/46/18710.full?sid=b685d344-5523-4371-a682-b03610d573e6
Effects of marijuana smoking on the lung (full–2013) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201212-127FR#.U903xGN8E24
Cannabis and the Lung: No More Smoking Gun? (editorial–2013) http://www.atsjournals.org/doi/abs/10.1513/AnnalsATS.201302-034ED?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed&
The effects of cannabidiol on the antigen-induced contraction of airways smooth muscle in the guinea-pig (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23428645
top
Protective effect of magnolol on lipopolysaccharide-induced acute lung injury in mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23053725
Health outcomes associated with long-term regular cannabis and tobacco smoking (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23501136
Synthetic Marijuana: Possibly A Lung’s Dying Breath (abst–2013) http://journal.publications.chestnet.org/article.aspx?articleid=1740537
Synthetic Cannabinoids as a Cause for Black Carbonaceous Bronchoalveolar Lavage (abst–2013) http://journal.publications.chestnet.org/article.aspx?articleid=1740090
Diffuse Hemorrhagic Pulmonary Infiltrates: Unique Complication Of Synthetic Cannabinoid Abuse (abst–2013) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A5043
The Synthetic Cannabinoid Ajulemic Acid Exerts Anti-Fibrotic Effects In Bleomycin Induced Pulmonary Fibrosis (abst–2013) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A5649
CB2 Receptor Activation Ameliorates the Proinflammatory Activity in Acute Lung Injury Induced by Paraquat (full–2014) http://www.hindawi.com/journals/bmri/2014/971750/
Cardiorespiratory Anomalies in Mice Lacking CB1 Cannabinoid Receptors (full–2014)  http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0100536
Effect of melilotus extract on lung injury by upregulating the expression of cannabinoid CB2 receptors in septic rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995869/
Cannabinoids inhibit cholinergic contraction in human airways through prejunctional CB1 receptors (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243853/
Effects of Marijuana Exposure on Expiratory Airflow: A Study of Adults who Participated in the U.S. National Health and Nutrition Examination Study (full–2014) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201407-333OC#.VrA9xVJA44A
Pulmonary Effects of Synthetic Marijuana: Chest Radiography and CT Findings (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25541904
Does cannabis smoking predispose to lung bulla formation? (full–2014) http://aan.sagepub.com/content/22/1/65.long
Cannabidiol improves lung function and inflammation in mice submitted to LPS-induced acute lung injury (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25356537
The Endocannabinoid Anandamide Mediates Hypoxic Pulmonary Vasoconstriction And Pulmonary Hypertension (abst–2014) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A5558
Acute Lung Injury Due To Synthetic Cannabis (abst–2014) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A6122
Cannabis, tobacco smoking, and lung function: a cross-sectional observational study in a general practice population (full–2015) http://bjgp.org/content/65/631/e89
top
Synthetic cannabinoids as a cause for black carbonaceous bronchoalveolar lavage (full–2015) http://casereports.bmj.com/content/2015/bcr-2015-211391.full.pdf
Unintentional Pediatric Exposure to a Synthetic Cannabinoid (AB-PINACA) Resulting in Coma and Intubation (full–2015)  http://www.annemergmed.com/article/S0196-0644%2815%2900426-6/fulltext
Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care, and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup (full–2015) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201504-195AR#.Vo20QFJwtSE
The Wide and Unpredictable Scope of Synthetic Cannabinoids Toxicity (full–2015) http://www.hindawi.com/journals/cricc/2015/542490/
No smoke, no fire: What the initial literature suggests regarding vapourized cannabis and respiratory risk (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456813/
Δ9 Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25425209
The effect of phytocannabinoids on airway hyper-responsiveness, airway inflammation, and cough (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25655949
Effects of quitting cannabis on respiratory symptoms (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25837035
Endogenous 2-Arachidonoylglycerol Alleviates Cyclooxygenases-2 Elevation-Mediated Neuronal Injury from SO2 Inhalation via PPARγ Pathway (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26209559
Protection from Radiation-Induced Pulmonary Fibrosis by Peripheral Targeting of Cannabinoid Receptor-1 (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599364/
How beneficial is vaping cannabis to respiratory health compared to smoking? (article–2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13075/full
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drug’s harm to children and adults, but the scientific evidence is seldom clear-cut (article–2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full
A New Threat: Synthetic Marijuana Associated Lung Disease (abst–2015) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4684
Dabble With Danger: A Case Of Severe Respiratory Failure Following Inhalation Of Butane Hash Oil (abst–2015) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4596
Acute Eosinophilic Pneumonia With Respiratory Failure Induced By ‘Bonzai’ (Synthetic Cannabinoid) Inhalation (abst–2015) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A1496
Cannabinoid Receptor Type 2 Agonist Attenuates Acute Neurogenic Pulmonary Edema by Preventing Neutrophil Migration after Subarachnoid Hemorrhage in Rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26463937
Peripheral Targeting of CB1 Cannabinoid Receptors Protects from Radiation-Induced Pulmonary Fibrosis (abst–2015) http://www.atsjournals.org/doi/abs/10.1165/rcmb.2014-0331OC#.VcgfrvlwtB8
Protection from Radiation-Induced Pulmonary Fibrosis by Peripheral Targeting of Cannabinoid Receptor-1 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26426981
Genotoxic properties of XLR-11, a widely consumed synthetic cannabinoid, and of the benzoyl indole RCS-4 (full–2016) http://link.springer.com/article/10.1007/s00204-016-1664-4/fulltext.html
A Randomized Placebo Controlled Trial of Ibuprofen for Respiratory Syncytial Virus Infection in a Bovine Model (full–2016) http://journals.plos.org/plosone/article? id=10.1371/journal.pone.0152913
Legal regulated markets have the potential to reduce population levels of harm associated with cannabis use (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/add.13390/full
Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899060/
Medical cannabis use in Canada: vapourization and modes of delivery (full–2016) https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-016-0119-9
Acute Eosinophilic Pneumonia with Respiratory Failure Induced by Synthetic Cannabinoid Inhalation (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156457/
Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy. (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801305/
Cannabinoid Receptor Type 2 Agonist Attenuates Acute Neurogenic Pulmonary Edema by Preventing Neutrophil Migration after Subarachnoid Hemorrhage in Rats (abst-2016) http://link.springer.com/chapter/10.1007/978-3-319-18497-5_24
The Endogenous Cannabinoid Anandamide Increases Human Airway Epithelial Cell Permeability through an Arachidonic Acid Metabolite (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816000256
Cannabinoid receptor 2 augments eosinophil responsiveness and aggravates allergen induced pulmonary inflammation in mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26850094
Stimulation of cannabinoid CB1 receptors prevents nerve-mediated airway hyperreactivity in NGF-induced inflammation in mouse airways (abst-2016) http://www.ncbi.nlm.nih.gov/pubmed/26896777
Cannabinoids: Medical implications (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26912385
Cannabis – Position Paper of the German Respiratory Society (DGP) (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26935046
Activation of cannabinoid CB1 receptors suppresses the ROS-induced hypersensitivity of rat vagal lung C-fiber afferents (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27328978
The cannabinoid 2 receptor agonist β-caryophyllene modulates the inflammatory reaction induced by Mycobacterium bovis BCG by inhibiting neutrophil migration (abst–2016) http://link.springer.com/article/10.1007%2Fs00011-016-0969-3
Alveolar haemorrhage following a cannabis water pipe (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27421143
Acute effects of cannabis on breath-holding duration (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27454678
Repeated Thrombosis After Synthetic Cannabinoid Use (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27595371
Δ9-Tetrahydrocannabinol Reverses TNFα-induced Increase in Airway Epithelial Cell Permeability through CB2 Receptors (abst–2016) http://www.sciencedirect.com/science/article/pii/S0006295216302878
Targeting brain and peripheral plasticity of the lipidome in acute kainic acid-induced epileptic seizures in mice via quantitative mass spectrometry (abst–2016) http://www.sciencedirect.com/science/article/pii/S1388198116303092
The consequences of chronic cannabis smoking in vulnerable adolescents (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27986504
Influence of history of cannabis smoking in selected donors on the outcomes of lung transplantation (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28077504
top